drugset
drugset / Trial / NCT00543296

Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment

NCT00543296 ↗

Phase 4 Completed 21 enrolled Duke University Bausch & Lomb Incorporated · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to collect data on patients with severe uveitis that have required re-implantation of the sustained-release fluocinolone drug delivery device due to depletion of study drug in their previous implanted device.

Timeline

Start
2004-03
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject fluocinolone acetonide Small molecule 0.59 mg Intravitreal

Indications

uveitis